Beijing Wandong Medical Technology Co Ltd
SSE:600055

Watchlist Manager
Beijing Wandong Medical Technology Co Ltd Logo
Beijing Wandong Medical Technology Co Ltd
SSE:600055
Watchlist
Price: 14.74 CNY -1.8% Market Closed
Market Cap: ¥10.4B

Income Statement

Earnings Waterfall
Beijing Wandong Medical Technology Co Ltd

Income Statement
Beijing Wandong Medical Technology Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Dec-2004 Mar-2005 Jun-2005 Sep-2005 Dec-2005 Mar-2006 Jun-2006 Sep-2006 Dec-2006 Mar-2007 Jun-2007 Sep-2007 Dec-2007 Mar-2008 Jun-2008 Sep-2008 Dec-2008 Mar-2009 Jun-2009 Sep-2009 Dec-2009 Mar-2010 Jun-2010 Sep-2010 Dec-2010 Mar-2011 Jun-2011 Sep-2011 Dec-2011 Mar-2012 Jun-2012 Sep-2012 Dec-2012 Mar-2013 Jun-2013 Sep-2013 Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Interest Expense
4
0
0
0
10
0
0
0
10
0
0
0
10
0
0
0
16
0
0
0
11
0
0
0
5
0
0
0
7
0
0
0
11
0
0
0
7
0
0
0
9
0
0
0
16
0
0
0
2
0
0
0
1
0
0
0
1
0
0
0
1
0
1
2
2
0
0
0
2
0
0
0
1
1
2
1
1
0
0
1
2
0
0
0
Revenue
480
N/A
480
+0%
463
-4%
462
0%
495
+7%
504
+2%
519
+3%
527
+2%
523
-1%
527
+1%
522
-1%
525
+1%
534
+2%
547
+2%
548
+0%
553
+1%
604
+9%
629
+4%
672
+7%
691
+3%
683
-1%
680
0%
660
-3%
670
+2%
603
-10%
639
+6%
636
-1%
633
0%
589
-7%
542
-8%
560
+3%
572
+2%
728
+27%
747
+3%
791
+6%
789
0%
765
-3%
726
-5%
732
+1%
718
-2%
740
+3%
766
+3%
779
+2%
819
+5%
818
0%
832
+2%
855
+3%
860
+1%
813
-5%
808
-1%
764
-6%
785
+3%
884
+13%
898
+2%
933
+4%
968
+4%
955
-1%
982
+3%
952
-3%
972
+2%
982
+1%
1 071
+9%
1 107
+3%
1 082
-2%
1 132
+5%
1 122
-1%
1 124
+0%
1 196
+6%
1 156
-3%
1 127
-3%
1 118
-1%
1 088
-3%
1 121
+3%
1 166
+4%
1 259
+8%
1 314
+4%
1 237
-6%
1 290
+4%
1 342
+4%
1 404
+5%
1 524
+9%
1 589
+4%
1 668
+5%
1 620
-3%
Gross Profit
Cost of Revenue
(321)
(323)
(306)
(305)
(342)
(350)
(364)
(368)
(360)
(363)
(357)
(355)
(370)
(379)
(377)
(387)
(405)
(426)
(468)
(464)
(474)
(470)
(438)
(456)
(387)
(405)
(410)
(405)
(389)
(362)
(367)
(376)
(496)
(508)
(543)
(529)
(512)
(493)
(501)
(495)
(519)
(550)
(554)
(582)
(546)
(550)
(557)
(551)
(499)
(491)
(453)
(469)
(522)
(542)
(562)
(574)
(543)
(572)
(542)
(555)
(527)
(545)
(557)
(527)
(577)
(590)
(612)
(657)
(635)
(635)
(640)
(632)
(631)
(684)
(739)
(774)
(715)
(764)
(796)
(859)
(971)
(1 023)
(1 105)
(1 108)
Gross Profit
159
N/A
157
-2%
157
N/A
157
+0%
153
-3%
154
+1%
155
+1%
159
+3%
164
+3%
164
+0%
166
+1%
170
+3%
164
-3%
169
+3%
171
+1%
166
-3%
198
+19%
203
+3%
205
+1%
227
+11%
210
-8%
211
+0%
222
+6%
214
-4%
216
+1%
234
+8%
227
-3%
228
+1%
200
-12%
180
-10%
193
+7%
196
+2%
231
+18%
239
+3%
248
+4%
260
+5%
253
-3%
233
-8%
230
-1%
223
-3%
221
-1%
216
-2%
225
+4%
237
+5%
272
+15%
282
+4%
298
+6%
309
+4%
314
+2%
318
+1%
311
-2%
316
+2%
362
+14%
356
-2%
371
+4%
395
+6%
412
+4%
410
0%
411
+0%
417
+2%
456
+9%
525
+15%
550
+5%
554
+1%
555
+0%
532
-4%
512
-4%
539
+5%
521
-3%
492
-6%
478
-3%
456
-5%
491
+8%
481
-2%
520
+8%
540
+4%
522
-3%
527
+1%
547
+4%
545
0%
553
+1%
567
+2%
562
-1%
512
-9%
Operating Income
Operating Expenses
(118)
(116)
(115)
(116)
(122)
(120)
(123)
(127)
(123)
(124)
(128)
(132)
(128)
(131)
(125)
(121)
(159)
(163)
(165)
(189)
(167)
(167)
(182)
(170)
(174)
(187)
(178)
(175)
(159)
(158)
(161)
(175)
(188)
(192)
(208)
(222)
(230)
(229)
(218)
(208)
(233)
(230)
(226)
(233)
(254)
(253)
(278)
(297)
(295)
(288)
(276)
(250)
(284)
(263)
(279)
(281)
(269)
(268)
(263)
(268)
(306)
(324)
(331)
(334)
(301)
(276)
(283)
(317)
(354)
(354)
(354)
(341)
(382)
(381)
(404)
(428)
(432)
(435)
(443)
(452)
(469)
(477)
(509)
(573)
Selling, General & Administrative
(120)
(119)
(117)
(118)
(126)
(123)
(126)
(129)
(118)
(118)
(122)
(126)
(123)
(126)
(121)
(117)
(152)
(157)
(157)
(181)
(159)
(160)
(174)
(162)
(166)
(179)
(170)
(167)
(153)
(153)
(156)
(169)
(162)
(187)
(203)
(217)
(202)
(221)
(212)
(202)
(205)
(223)
(220)
(227)
(209)
(248)
(272)
(290)
(230)
(276)
(276)
(260)
(255)
(284)
(293)
(280)
(251)
(239)
(218)
(224)
(271)
(282)
(295)
(292)
(248)
(227)
(235)
(251)
(282)
(277)
(263)
(251)
(272)
(273)
(289)
(309)
(320)
(313)
(303)
(311)
(325)
(329)
(356)
(387)
Research & Development
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(17)
0
0
0
(19)
0
0
0
(22)
0
0
0
(36)
0
0
0
(57)
0
0
0
(62)
0
0
(14)
(39)
(49)
(65)
(65)
(48)
(74)
(80)
(83)
(69)
(81)
(79)
(95)
(99)
(117)
(123)
(123)
(127)
(142)
(153)
(164)
(143)
(164)
(172)
(163)
(150)
(186)
(194)
(232)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(9)
0
0
0
(10)
0
0
0
(5)
0
0
0
(8)
0
0
0
(8)
0
0
0
(5)
0
0
0
(27)
0
0
0
(28)
0
0
0
(23)
0
0
0
(17)
0
0
0
(17)
0
0
0
(18)
0
0
0
(20)
0
0
0
Other Operating Expenses
2
3
2
2
4
3
3
0
(5)
(5)
(5)
(5)
(5)
(5)
(5)
(5)
(7)
(6)
(8)
(8)
(8)
(8)
(8)
(8)
(8)
(8)
(8)
(8)
(6)
(6)
(6)
(6)
(1)
(5)
(5)
(5)
(1)
(8)
(6)
(6)
(0)
(7)
(7)
(6)
(2)
(5)
(7)
(7)
(0)
(13)
(1)
10
37
21
14
13
49
21
20
22
41
32
44
41
39
32
31
30
44
40
31
33
34
34
38
44
49
42
32
22
26
38
41
45
Operating Income
41
N/A
41
0%
42
+3%
41
-2%
30
-27%
34
+11%
31
-7%
32
+2%
41
+27%
40
-2%
38
-4%
38
+0%
37
-4%
38
+3%
46
+21%
45
-2%
40
-12%
41
+3%
40
-2%
39
-2%
43
+10%
43
+1%
40
-7%
44
+10%
42
-6%
47
+13%
49
+4%
53
+9%
41
-23%
22
-46%
32
+44%
21
-34%
43
+104%
47
+10%
40
-15%
38
-4%
23
-41%
4
-81%
12
+193%
15
+24%
(12)
N/A
(14)
-19%
(1)
+92%
4
N/A
18
+403%
29
+62%
20
-31%
12
-39%
19
+56%
29
+55%
35
+20%
66
+89%
78
+19%
93
+19%
92
-1%
114
+23%
143
+26%
142
-1%
148
+4%
149
+1%
150
+1%
201
+34%
220
+9%
220
+0%
254
+15%
256
+1%
229
-10%
222
-3%
167
-24%
138
-18%
123
-10%
115
-7%
109
-6%
100
-8%
116
+16%
112
-3%
90
-19%
92
+1%
104
+13%
94
-10%
84
-10%
90
+6%
54
-40%
(62)
N/A
Pre-Tax Income
Interest Income Expense
(2)
(2)
(4)
(4)
(9)
(10)
(9)
(9)
(8)
(7)
(9)
(9)
(12)
(12)
(15)
(15)
(16)
(16)
(15)
(13)
(8)
(7)
(4)
(5)
(3)
(4)
(4)
(4)
(4)
(5)
(6)
(7)
(8)
(10)
(10)
(8)
(4)
(3)
(1)
(2)
(1)
(3)
(4)
(6)
(4)
(3)
3
12
31
34
39
39
40
37
39
32
34
39
34
40
40
39
40
39
10
9
11
11
42
43
56
75
89
99
101
96
123
124
118
113
80
75
66
65
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
(0)
0
0
0
(1)
0
0
0
(1)
0
0
0
(1)
0
0
0
0
0
0
0
(1)
(0)
(0)
(0)
0
0
0
0
(0)
(0)
(0)
(0)
(5)
(1)
(2)
(2)
(0)
0
(0)
(0)
(1)
0
0
0
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
(0)
0
26
0
(1)
0
0
0
0
(0)
(0)
(0)
(0)
(1)
(1)
0
(2)
(0)
(1)
0
0
0
(4)
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
(0)
0
0
0
(0)
0
0
0
(0)
0
0
0
Total Other Income
(1)
(1)
(1)
(0)
0
(2)
0
(2)
0
0
2
2
5
5
2
2
9
10
11
11
38
38
39
39
7
8
6
6
15
26
26
30
6
2
5
3
0
27
26
24
40
39
43
42
37
37
39
45
33
29
13
6
2
(7)
2
3
(0)
(4)
(6)
(6)
2
2
4
4
(0)
0
(0)
(0)
(2)
0
(1)
(1)
0
(0)
(0)
(1)
0
(0)
1
0
4
4
3
4
Pre-Tax Income
38
N/A
38
-1%
37
-3%
37
+1%
21
-43%
22
+2%
22
N/A
21
-5%
32
+57%
33
+1%
31
-3%
32
+2%
30
-5%
31
+1%
33
+8%
32
-4%
33
+3%
34
+4%
36
+4%
37
+3%
74
+101%
75
+1%
76
+1%
79
+4%
45
-42%
51
+11%
51
+1%
55
+7%
53
-5%
43
-18%
52
+19%
44
-15%
41
-6%
40
-4%
36
-11%
34
-5%
45
+34%
29
-37%
37
+28%
38
+3%
28
-27%
22
-20%
37
+70%
40
+6%
50
+26%
62
+24%
61
-1%
68
+11%
81
+20%
91
+12%
84
-7%
110
+30%
119
+8%
122
+3%
134
+9%
148
+11%
173
+17%
176
+2%
176
0%
182
+3%
191
+5%
242
+27%
264
+9%
263
0%
264
+0%
264
+0%
240
-9%
233
-3%
207
-11%
179
-14%
178
-1%
189
+6%
192
+2%
197
+3%
215
+9%
205
-5%
213
+4%
215
+1%
222
+3%
207
-7%
167
-19%
168
+1%
123
-27%
7
-95%
Net Income
Tax Provision
(6)
(5)
(5)
(5)
(3)
(3)
(2)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(4)
(4)
(4)
(4)
(4)
(3)
(4)
(4)
(4)
(5)
(3)
(4)
(3)
(4)
(12)
(11)
(12)
(12)
(6)
(5)
(2)
(2)
(1)
(1)
(0)
0
(2)
(2)
(2)
(2)
(7)
(7)
(7)
(8)
(13)
0
(20)
(26)
(18)
(21)
(20)
(20)
(24)
(23)
(23)
(26)
(26)
(34)
(38)
(42)
(46)
(46)
(44)
(42)
(27)
(22)
(20)
(25)
(20)
(21)
(25)
(15)
(23)
(20)
(23)
(21)
(8)
(9)
2
8
Income from Continuing Operations
33
33
32
32
19
19
19
18
30
31
29
30
28
28
29
28
29
30
32
34
69
70
71
74
43
47
48
51
41
33
39
32
36
35
33
32
45
28
37
38
25
20
35
37
43
55
54
60
68
78
64
85
101
102
114
128
149
153
153
156
165
209
226
221
218
218
196
191
180
157
157
164
172
176
190
191
191
195
199
186
159
159
125
14
Income to Minority Interest
(1)
(0)
1
1
(1)
(1)
(1)
(1)
(0)
(0)
0
0
0
0
(1)
(0)
(1)
(1)
(1)
(1)
(1)
(0)
(1)
(1)
(1)
(1)
(0)
(0)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
1
1
0
1
(0)
(0)
(2)
(3)
(1)
0
3
5
5
5
8
9
7
6
4
2
2
0
4
5
4
5
2
1
2
2
3
2
2
2
3
5
2
2
(2)
(4)
(1)
(2)
(1)
(0)
(1)
(0)
Net Income (Common)
32
N/A
32
+1%
32
-1%
33
+3%
18
-47%
18
+1%
18
+2%
17
-9%
30
+83%
31
+1%
30
-3%
31
+3%
28
-9%
29
+2%
29
+1%
27
-5%
28
+4%
29
+3%
32
+9%
33
+3%
69
+109%
70
+2%
71
+1%
73
+3%
42
-43%
46
+10%
48
+4%
51
+6%
40
-22%
32
-20%
38
+19%
31
-18%
34
+10%
34
-2%
32
-7%
31
-3%
44
+43%
27
-37%
37
+36%
39
+5%
26
-34%
21
-20%
35
+69%
37
+6%
40
+9%
51
+27%
53
+3%
60
+14%
72
+19%
83
+16%
69
-16%
90
+29%
109
+22%
110
+1%
121
+10%
134
+11%
153
+14%
155
+1%
155
0%
156
+1%
169
+8%
214
+27%
230
+7%
226
-2%
221
-2%
219
-1%
199
-9%
193
-3%
183
-5%
159
-13%
159
+0%
166
+4%
175
+6%
181
+3%
192
+6%
192
+0%
189
-2%
191
+1%
197
+3%
184
-7%
157
-15%
159
+1%
124
-22%
14
-88%
EPS (Diluted)
0.07
N/A
0.07
N/A
0.07
N/A
0.07
N/A
0.04
-43%
0.04
N/A
0.05
+25%
0.05
N/A
0.06
+20%
0.07
+17%
0.06
-14%
0.06
N/A
0.06
N/A
0.06
N/A
0.06
N/A
0.06
N/A
0.06
N/A
0.06
N/A
0.07
+17%
0.07
N/A
0.14
+100%
0.14
N/A
0.14
N/A
0.14
N/A
0.09
-36%
0.09
N/A
0.09
N/A
0.1
+11%
0.08
-20%
0.06
-25%
0.08
+33%
0.06
-25%
0.07
+17%
0.06
-14%
0.05
-17%
0.05
N/A
0.09
+80%
0.05
-44%
0.07
+40%
0.08
+14%
0.05
-38%
0.04
-20%
0.07
+75%
0.07
N/A
0.08
+14%
0.1
+25%
0.1
N/A
0.11
+10%
0.13
+18%
0.15
+15%
0.12
-20%
0.16
+33%
0.2
+25%
0.21
+5%
0.23
+10%
0.25
+9%
0.28
+12%
0.28
N/A
0.28
N/A
0.29
+4%
0.31
+7%
0.39
+26%
0.42
+8%
0.41
-2%
0.41
N/A
0.4
-2%
0.36
-10%
0.35
-3%
0.34
-3%
0.3
-12%
0.24
-20%
0.22
-8%
0.27
+23%
0.26
-4%
0.28
+8%
0.28
N/A
0.27
-4%
0.27
N/A
0.28
+4%
0.26
-7%
0.22
-15%
0.22
N/A
0.17
-23%
0.02
-88%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett